Abnormalities of cytokine and growth factor signaling pathways are characteristic of all forms of leukemia: lymphoid and myeloid, acute and chronic. In normal hematopoietic cells, cytokines provide the stimulus for proliferation, survival, self-renewal, differentiation and functional activation. In leukemic cells, these pathways are usurped to subserve critical parts of the malignant program. In this review, our current knowledge of leukemic cell cytokine signaling will be summarized, and some speculations on the significance and implications of these insights will be advanced. A better understanding of aberrant cytokine signaling in leukemia should provide additional targets for the rational therapy of these diseases. © 2007 Nature Publishing Group All rights reserved.
CITATION STYLE
Van Etten, R. A. (2007, October 15). Aberrant cytokine signaling in leukemia. Oncogene. https://doi.org/10.1038/sj.onc.1210758
Mendeley helps you to discover research relevant for your work.